Increasing kidney cancer incidence and survival in Estonia: role of age and stage

被引:10
作者
Innos, Kaire [1 ]
Sepp, Teesi [2 ]
Baburin, Aleksei [1 ]
Kotsar, Andres [2 ]
Lang, Katrin [3 ]
Padrik, Peeter [4 ,5 ]
Aareleid, Tiiu [1 ]
机构
[1] Natl Inst Hlth Dev, Dept Epidemiol & Biostat, Hiiu 42, EE-11619 Tallinn, Estonia
[2] Tartu Univ Hosp, Surg Clin, Dept Urol & Kidney Transplantat, Tartu, Estonia
[3] Univ Tartu, Inst Family Med & Publ Hlth, Tartu, Estonia
[4] Tartu Univ Hosp, Clin Haematol & Oncol, Tartu, Estonia
[5] Univ Tartu, Inst Clin Med, Tartu, Estonia
关键词
RENAL-CELL CARCINOMA; INTERFERON-ALPHA; NORDIC COUNTRIES; BLOOD-PRESSURE; TRENDS; POPULATION; HYPERTENSION; METAANALYSIS; PREVALENCE; RISK;
D O I
10.1080/0284186X.2018.1512158
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Kidney cancer rates in Estonia are high. The study aimed to examine long-term trends in kidney cancer incidence, mortality and survival in Estonia, with special focus on age, birth cohorts, morphology and TNM stage.Material and methods: Estonian Cancer Registry provided data on all incident cases of kidney cancer (ICD-10 C64), diagnosed in adults (age 15 years) in Estonia during 1995-2014. Relative survival ratios (RSR) were calculated and excess hazard ratios of dying were estimated with gender, age, period of diagnosis and TNM stage as independent variables. Joinpoint regression modeling was used to calculate estimated annual percentage change for incidence (1970-2014) and mortality (1995-2016) trends. Age-specific incidence rates were presented by birth cohort and period of diagnosis.Results: Incidence increased significantly in both sexes, with the steepest rise seen for localized cancer. Cohort effects were pronounced particularly in men, while period effects were seen from the mid-1980s to mid-1990s in both sexes. Age-standardized five-year RSR for total kidney cancer increased by 13 percentage units (from 53% to 65%) over the study period; the increase was larger for renal cell carcinoma (from 63% to 78%). Survival increases of about five percentage units were seen for stages I/II and III. Age and gender were not associated with excess risk of dying from renal cell carcinoma after adjusting for stage.Conclusion: Estonia is currently among countries with the highest incidence of kidney cancer. The results suggest a combined effect of changing risk profiles in successive birth cohorts and increasing diagnostic activity around 1990. Large survival increase can mostly be attributed to earlier detection, but improved diagnosis and treatment have probably influenced stage-specific survival. High proportion of tumors with unspecified morphology and those with unknown stage among the elderly warrants further investigation of diagnostic and treatment practices.
引用
收藏
页码:21 / 28
页数:8
相关论文
共 51 条
  • [1] Trends in cancer patient survival in Estonia before and after the transition from a soviet republic to an open-market economy
    Aareleid, T
    Brenner, H
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2002, 102 (01) : 45 - 50
  • [2] Divergent trends in lung cancer incidence by gender, age and histological type in Estonia: a nationwide population-based study
    Aareleid, Tiiu
    Zimmermann, Mari-Liis
    Baburin, Aleksei
    Innos, Kaire
    [J]. BMC CANCER, 2017, 17
  • [3] American Joint Committee on Cancer, 1992, MANUAL STAGING CANC
  • [4] [Anonymous], 2009, TNM classification of malignant tumors, V7th edn
  • [5] [Anonymous], 2017, ONC GUID REN CELL CA
  • [6] [Anonymous], 2018, CANC RES UK
  • [7] [Anonymous], 2004, INT RUL MULT PRIM CA
  • [8] Cancers in France in 2015 attributable to high body mass index
    Arnold, Melina
    Touillaud, Marina
    Dossus, Laure
    Freisling, Heinz
    Bray, Freddie
    Margaritis, Irene
    Deschamps, Valerie
    Soerjomataram, Isabelle
    [J]. CANCER EPIDEMIOLOGY, 2018, 52 : 15 - 19
  • [9] The surgical management of elderly cancer patients: recommendations of the SIOG surgical task force
    Audisio, RA
    Bozzetti, F
    Gennari, R
    Jaklitsch, MT
    Koperna, T
    Longo, WE
    Wiggers, T
    Zbar, AP
    [J]. EUROPEAN JOURNAL OF CANCER, 2004, 40 (07) : 926 - 938
  • [10] Real-life use of diagnostic biopsies before treatment of kidney cancer: results from a Norwegian population-based study
    Beisland, Christian
    Johannesen, Tom B.
    Reisaeter, Lars Anders R.
    Hjelle, Karin M.
    [J]. SCANDINAVIAN JOURNAL OF UROLOGY, 2018, 52 (01) : 38 - 44